You are here: Industry Insights > orphan drugs

News List

Piramal Pharma Solutions to join hands with Epirium Bio to develop and manufacture orphan drugs expresspharma
August 28, 2020
The integrated programme, involving three Piramal Pharma Solutions sites, encompasses formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
Orphan drugs face uphill battle in 2020: GlobalData expresspharma
March 03, 2020
ODDs have been a focus of interest from the pharma industry for many years, with many companies enticed by the benefits of the enhanced regulatory processes, tax benefits and extended market exclusivity.
Biologics or small molecule drugs for rare disease treatment? It is a question PharmaSources/Miling
July 31, 2019
To both patients and pharmaceutical practitioners, it is a question as to whether to choose biologics or small molecule drugs for rare disease treatment, since the prices are sky-high.
Little Orphan Drugs Can Lead to Big Market Rare Disease Drugs in China zhulikou431
January 22, 2018
In the Ice Bucket Challenge in 2014, the “amyotrophic lateral sclerosis” (ALS) patients attracted the world’s attention, and more people started to pay attention to the rare diseases.
Rare disease in EU Zhulikou431
January 09, 2018
According to some information released by the European Medicines Agency (EMA), there are about 30 million people in Europe suffering from rare diseases, the incidence of most diseases less than one hundred thousandth.
Rare disease in America Zhulikou431
January 09, 2018
Rare disease is a general term for a group of diseases with a very low incidence, also known as orphan disease.
Rhizen receives US FDA orphan drug designation expressbpd
December 27, 2017
The US Food and Drug Administration (US FDA) has granted orphan drug designation for Tenalisib (RP6530) for the treatment of patients with peripheral T-cell lymphoma (PTCL), Alembic Pharmaceuticals said in a BSE filing.
FDA grants orphan drug status to Shire’s UC treatment SHP647 pharmaceutical-technology
December 04, 2017
FDA has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1 antibody, SHP647, for the treatment of paediatric patients with moderately to severely active ulcerative colitis
GST makes ‘orphan drugs’ prices soar indiatimes
November 27, 2017
MUMBAI: Prices of exorbitantly-priced life-saving medicines, used to treat rare diseases have increased by 12%, with implementation of Goods and Services Tax, resulting in skyrocketing bills and leaving many patients in the lurch.
GNH India clears audit to trade orphan drugs with UK expressbpd
July 11, 2017
Orphan drugs such as Ferripox, Raxone, Trientine and Mitocin will now available to the Indian population.

Previous page 1 2 Next page